No significant change in total healthcare costs with aripiprazole lauroxil
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news

Novel model shows LAI aripiprazole may be cost effective
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news

aripiprazole (Abilify)
Title: aripiprazole (Abilify)Category: MedicationsCreated: 2/17/2004 12:00:00 AMLast Editorial Review: 8/6/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 6, 2021 Category: Drugs & Pharmacology Source Type: news

Spectrum Reporting Prompts New Review of Common Drug
The review of more than two dozen studies finds aripiprazole has side effects and does not change core autism features, but parents report improvements in self-injury, tantrums, and other challenging... (Source: The Scientist)
Source: The Scientist - February 11, 2021 Category: Science Tags: News & Opinion Source Type: news

What Is the Most Common Side Effect of Abilify
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 22, 2020 Category: General Medicine Source Type: news

How to manage patients on long-acting injectable (LAI, or depot) antipsychotics during the COVID-19 pandemic, NIHR
This guidance includes information about LAI antipsychotic medications which are currently licensed in the UK (that is: Xeplion ® , Trevicta ® , Abilify Maintena ® , Risperdal Consta ® , Zypadhera ® ) (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

Class 4 Medicines Defect Information: Aripiprazole 1mg/ml Oral Solution,
Mylan UK Healthcare Ltd has informed the MHRA that a product complaint ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 12, 2020 Category: Drugs & Pharmacology Source Type: news

How Aripiprazole's Promise for Treating Autism Fell Short
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade's worth of data suggests that is not true. (Source: The Scientist)
Source: The Scientist - February 27, 2020 Category: Science Tags: News & Opinion Source Type: news

Class 2 Medicines Recall: Aripiprazole 1mg/ml oral solution
Dr. Reddy's Laboratories (UK) Ltd is recalling a specified batch of Aripiprazole 1mg/ml oral solution due to the potential for small particles of Aripiprazole active material to be present which m (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 12, 2019 Category: Drugs & Pharmacology Source Type: news